Iron Supplementation Relieves Dysautonomia in Non-Anemic Female
-
1
Carrick Institute, United States
Background:
A forty-six-year-old female presented with chief complaint of anxiety. She has a history of menorrhagia. Medications included transdermal progesterone. Supplements included multi-vitamin, phosphatidylserine, St. John’s Wort, and probiotic.
Methods:
A five-minute heart rate variability study was performed which showed normal heart rate variability and elevated mean heart rate (91 bpm) when compared to age and sex-related norms (figure 1). Heart rate variability testing when measured seated to standing showed total adaptive cardiovascular dysfunction (figure 2).
Blood chemistry revealed low iron saturation (9) and clinically significant laboratory results as follows: RBC (4.0), hemoglobin (11.6), hematocrit (34.5), MCV (86), MCH (29), MCHC (33.6), RDW (14.6), TIBC (398), UIBC (362), iron (36), and ferritin (24).
She was placed on iron supplementation (27 mg ferrous bis-glycinate chelate) twice daily.
Results:
After 30 days, symptoms of anxiety were relieved, five-minute resting heart rate reduced to a normal of 74 bpm (figure 3), and seated to standing heart rate variability testing showed normal cardiovascular adaptive dysfunction (figure 4).
Conclusion:
Treatment of iron deficiency in the absence of overt anemia might be helpful in the management of dysautonomia. Further investigation into iron supplementation in the treatment of patients with dysautonomia is suggested.
Keywords:
iron deficiency,
dysautonomia,
Menorrhagia,
Anxiety,
Anemia
Conference:
International Symposium on Clinical Neuroscience 2018, Orlando, Florida, United States, 24 May - 26 May, 2018.
Presentation Type:
Poster
Topic:
Clinical Applications in health, disease, and injury to the nervous system
Citation:
Caffery
C
(2018). Iron Supplementation Relieves Dysautonomia in Non-Anemic Female.
Front. Neurol.
Conference Abstract:
International Symposium on Clinical Neuroscience 2018.
doi: 10.3389/conf.fneur.2018.60.00076
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
31 Mar 2018;
Published Online:
14 Dec 2018.
*
Correspondence:
Dr. Chris Caffery, Carrick Institute, Cape Canaveral, United States, drcaffery@gmail.com